Phibro Animal Health (PAHC) News
NASDAQ: PAHCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
38.30+0.90 (+2.41%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
PAHC news summary
We found 3 recent headlines mentioning Phibro Animal Health (PAHC): 3 in the past week and 3 in the past 30 days, most often from Nasdaq. For price context, PAHC is up 2.41% at $38.30. The most recent story, "Is it the Right Time to Hold TNDM Stock in Your Portfolio?", was published by Nasdaq on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Phibro Animal Health headlines
- Is it the Right Time to Hold TNDM Stock in Your Portfolio?Tandem Diabetes is advancing next-generation insulin delivery technology and international expansion, but competition and supply constraints pose challenges to growth.NasdaqTNDM, ABT, GMED, PAHC
- Is it the Right Time to Add Phibro Stock to Your Portfolio?PAHC's Animal Health gains from MFA, vaccine and mineral nutrition growth, but tariffs, costs and currency swings remain key risks to its outlook.NasdaqPAHC, ABT, GMED, VCYT
- Is This the Right Time to Add TMO Stock to Your Portfolio?Thermo Fisher's growth gains momentum through innovation, acquisitions and broad end-market strength, but macroeconomic and currency risks remain.NasdaqTMO, GMED, PAHC, VCYT